Comprehensive Assessment of Neurodegeneration and Dementia

This is a longitudinal observational study recruiting individuals between the ages of 50 and 90 with different types of dementia as well as a comparison group without cognitive deficits. Participants are/will be recruited at sites across Canada and will undergo assessments, neuroimaging, and biological sample collection.

Study identifier: NCT03402919. Status: RECRUITING.

Eligibility

Criteria: Inclusion Criteria: * Has subjective or objective cognitive impairment * Written informed consent must be obtained and documented (from the patient or, where jurisdictions allow it, from a caregiver/family member) * Sufficient proficiency in English or French to undertake self report and neuropsychological testing * Geographic accessibility to the study site * Must have a study partner who can participate as required in the protocol (provide corroborative information) * Up to 12 years of education * Fits into one of the following groups: Cognitively Unimpaired, Subjective Cognitive Impairment, Mild Cognitive Impairment, Vascular Mild Cognitive Impairment, Parkinson's Disease, Parkinson's Disease with Mild Cognitive Impairment Exclusion Criteria: * The presence of other significant known chronic brain disease such as: moderate to severe chronic static leukoencephalopathy (including previous traumatic injury), multiple sclerosis, a serious developmental handicap, malignant tumors, Parkinson's disease (other than for the Parkinson's cohort), and other rarer brain illnesses * Ongoing alcohol or drug abuse which in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures * Symptomatic stroke within the previous year * Unable to undergo MRI scan due to medical contraindications or inability to tolerate the procedure

  • Minimum age: 50 Years
  • Maximum age: 90 Years

Participating locations

  • University of Calgary, Calgary, Alberta
  • University of Alberta Hospital, Edmonton, Alberta
  • Djavad Mowafaghian Centre for Brain Health, Vancouver, British Columbia
  • Island Health, Victoria, British Columbia
  • Veteran's Memorial Building, Halifax, Nova Scotia
  • Hamilton General Hospital, Hamilton, Ontario
  • St. Joseph's Health Care London, London, Ontario
  • Gait and Brain Lab, London, Ontario
  • Bruyère Research Institute, Ottawa, Ontario
  • Kawartha Centre, Peterborough, Ontario

Study records are sourced from ClinicalTrials.gov. Confirm current eligibility, recruiting status, and locations in the official record.

View the official ClinicalTrials.gov record for NCT03402919

Browse Parkinson's clinical trials